Literature DB >> 15740938

The incidence of gastroesophageal reflux after transthoracic esophagocardio-myotomy without fundoplication: a long term follow-up.

Joerg Lindenmann1, Alfred Maier, Andreas Eherer, Veronika Matzi, Florian Tomaselli, Josef Smolle, Freyja Maria Smolle-Juettner.   

Abstract

OBJECTIVE: Evaluation of the long term results of Heller's myotomy performed over a lateral thoracotomy without additional fundoplication.
METHODS: Forty patients (17 males, 23 females; mean age 43.2 years; range: 14-63 years) were operated between 1985 and 2000. Preoperative evaluation included clinical scoring of symptoms, esophagogram, endoscopy, manometry and 24-h ph-metry. At the follow-up investigation, the preoperative evaluation was repeated in all patients, adding a histological workup of the distal esophageal mucosa. The mean duration of follow-up after surgery was 10.3 years, ranging from 3-16 years.
RESULTS: The clinical scores improved significantly: Excellent relief from dysphagia was present in 86%, little or no regurgitation was found in 79%, little or no retrosternal spasms were reported by 72% of the patients. Esophagogram showed an overall esophageal dilatation in all patients but no significant obstruction at the esophagogastric junction. Endoscopically, 2.5% had candida-esophagitis, 5% showed signs of a GERD I, 92.5% had a macroscopically insuspect esophageal mucosa. Histologically, 53% showed a mild chronic inflammation. Manometry demonstrated distinct hypomotility of the esophagus in all cases, yet no elevated pressure of the lower sphincter; pH-metry showed moderate reflux in 46%.
CONCLUSIONS: Transthoracic cardiomyotomy is a valid method for the treatment of achalasia, but it will not improve the esophageal motility, which slowly deterioriates in these cases. The patient's subjective assessment of the postoperative result was positive in the majority of cases. Although fundoplication was not done in any of these patients, none of them showed signs of clinically relevant reflux.

Entities:  

Mesh:

Year:  2005        PMID: 15740938     DOI: 10.1016/j.ejcts.2004.12.026

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

Review 1.  Surgical treatment for achalasia: when should it be performed, and for which patients?

Authors:  Hideyuki Kashiwagi; Nobuo Omura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

Review 2.  Impact of minimally invasive surgery on the treatment of benign esophageal disorders.

Authors:  Brian Bello; Fernando A Herbella; Marco E Allaix; Marco G Patti
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

3.  Laparoscopic calibrated total vs partial fundoplication following Heller myotomy for oesophageal achalasia.

Authors:  Natale Di Martino; Antonio Brillantino; Luigi Monaco; Luigi Marano; Michele Schettino; Raffaele Porfidia; Giuseppe Izzo; Angelo Cosenza
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

Review 4.  Evolution of the minimally invasive treatment of esophageal achalasia.

Authors:  Brian Bello; Fernando A Herbella; Marco G Patti
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

Review 5.  Fundoplication after laparoscopic Heller myotomy for esophageal achalasia: what type?

Authors:  Marco G Patti; Fernando A Herbella
Journal:  J Gastrointest Surg       Date:  2010-03-19       Impact factor: 3.452

Review 6.  The Evolution of the Treatment of Esophageal Achalasia: From the Open to the Minimally Invasive Approach.

Authors:  Francisco Schlottmann; Fernando A M Herbella; Marco G Patti
Journal:  World J Surg       Date:  2022-02-15       Impact factor: 3.282

Review 7.  Surgery or Peroral Esophageal Myotomy for Achalasia: A Systematic Review and Meta-Analysis.

Authors:  Luigi Marano; Giovanni Pallabazzer; Biagio Solito; Stefano Santi; Alessio Pigazzi; Raffaele De Luca; Francesco Giuseppe Biondo; Alessandro Spaziani; Maurizio Longaroni; Natale Di Martino; Virginia Boccardi; Alberto Patriti
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.